Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human CXCL5/ENA-78 Protein

Catalog No. 254XB025CF
Click to view available options
Formulation:
Lyophilized from a 0.2μm filtered solution in PBS.
Lyophilized from a 0.2mm filtered solution in PBS containing BSA as carrier protein
This item is not returnable. View return policy
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human CXCL5/ENA-78 Protein is derived from E. coli. The Recombinant Human CXCL5/ENA-78 Protein has been validated for the following applications: Bioactivity.

Specifications

Formulation Lyophilized from a 0.2μm filtered solution in PBS.
Gene ID (Entrez) 6374
Molecular Weight (g/mol) 8.4 kDa
Name CXCL5/ENA-78
Quantity 25 μg
Source E. coli-derived human CXCL5/ENA-78 protein Ala37-Asn114
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Conjugate Unconjugated
Recombinant Recombinant
Activity Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CXCR2. The ED50 is 3-15 ng/mL.
Purity or Quality Grade 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.